Brief: Nykode Therapeutics Q2 Operating Loss Of $11.8 Mln
Aug 21 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* Q2 TOTAL REVENUE AND OTHER INCOME $0.6 MILLION VERSUS $5.1
MILLION YEAR AGO
* Q2 OPERATING LOSS $11.8 MILLION VERSUS LOSS $11.9 MILLION
YEAR
AGO
Source text for Eikon: ID:nObiRbFHLa
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026